• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性婴儿高钙血症:病例报告及文献综述

Idiopathic infantile hypercalcemia: case report and review of the literature.

作者信息

Marks Brynn E, Doyle Daniel A

出版信息

J Pediatr Endocrinol Metab. 2016 Feb;29(2):127-32. doi: 10.1515/jpem-2015-0133.

DOI:10.1515/jpem-2015-0133
PMID:26501157
Abstract

The widespread use of supplemental vitamin D has dramatically reduced the incidence of rickets. While generally considered a safe practice, there is potential for toxicity in patients with idiopathic infantile hypercalcemia (IIH). Inadequate 24-hydroxylase-enzyme activity renders these individuals unable to degrade active vitamin D, resulting in hypercalcemia due to increased intestinal calcium absorption, decreased renal calcium excretion, and increased osteoclastic bone activity. Clinicians should be aware that even therapeutic doses of vitamin D can prove harmful for patients with CYP24A1 mutations. Studies have also demonstrated a link between inadequate 24-hydroxylase activity and nephrocalcinosis, renal insufficiency, and calcium containing kidney stones, further emphasizing the importance of early recognition of this disease and judicious use of vitamin D. We present a case with an interesting diagnostic algorithm used to diagnose IIH when given an incomplete history and subsequently review the existing literature on the subject.

摘要

补充维生素D的广泛使用已显著降低了佝偻病的发病率。虽然一般认为这是一种安全的做法,但特发性婴儿高钙血症(IIH)患者存在中毒的可能性。24-羟化酶活性不足使这些个体无法降解活性维生素D,由于肠道钙吸收增加、肾钙排泄减少和破骨细胞骨活性增加而导致高钙血症。临床医生应意识到,即使是治疗剂量的维生素D对携带CYP24A1突变的患者也可能有害。研究还表明,24-羟化酶活性不足与肾钙质沉着症、肾功能不全和含钙肾结石之间存在联系,这进一步强调了早期识别这种疾病和谨慎使用维生素D的重要性。我们介绍了一个病例,该病例采用了一种有趣的诊断算法,用于在病史不完整的情况下诊断IIH,并随后回顾了关于该主题的现有文献。

相似文献

1
Idiopathic infantile hypercalcemia: case report and review of the literature.特发性婴儿高钙血症:病例报告及文献综述
J Pediatr Endocrinol Metab. 2016 Feb;29(2):127-32. doi: 10.1515/jpem-2015-0133.
2
Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations.因 CYP24A1 突变导致维生素 D 24-羟化作用受损的患者的肾功能和阳光暴露的影响。
Am J Kidney Dis. 2015 Jan;65(1):122-6. doi: 10.1053/j.ajkd.2014.06.037. Epub 2014 Nov 4.
3
CYP24A1 Mutation in a Girl Infant with Idiopathic Infantile Hypercalcemia.一名患有特发性婴儿高钙血症女婴的CYP24A1基因突变
J Clin Res Pediatr Endocrinol. 2018 Mar 1;10(1):83-86. doi: 10.4274/jcrpe.4841. Epub 2017 Sep 6.
4
A rapid screening of a recurrent CYP24A1 pathogenic variant opens the way to molecular testing for Idiopathic Infantile Hypercalcemia (IIH).一种 CYP24A1 致病性变异的快速筛查方法为特发性婴儿高钙血症(IIH)的分子检测开辟了道路。
Clin Chim Acta. 2018 Jul;482:8-13. doi: 10.1016/j.cca.2018.03.024. Epub 2018 Mar 21.
5
Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases.CYP24A1或SLC34A1双等位基因突变作为维生素D超敏性婴儿特发性高钙血症(IIH)的病因:11例既往IIH病例的分子研究
J Appl Genet. 2017 Aug;58(3):349-353. doi: 10.1007/s13353-017-0397-2. Epub 2017 May 3.
6
[New Mutation of CYP24A1 in a Case of Idiopathic Infantile Hypercalcemia Diagnosed in Adulthood].[成年期诊断的特发性婴儿高钙血症病例中CYP24A1的新突变]
G Ital Nefrol. 2023 Dec 22;40(6):2023-vol6.
7
Molecular characterization of a recurrent 10.9 kb CYP24A1 deletion in Idiopathic Infantile Hypercalcemia.特发性婴儿高钙血症中复发性10.9 kb CYP24A1缺失的分子特征分析
Eur J Med Genet. 2019 Nov;62(11):103577. doi: 10.1016/j.ejmg.2018.11.011. Epub 2018 Nov 10.
8
Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: A cross-sectional study.CYP24A1突变杂合携带者的钙和骨稳态:一项横断面研究。
Bone. 2015 Dec;81:89-96. doi: 10.1016/j.bone.2015.06.018. Epub 2015 Jun 25.
9
Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia.编码钠磷协同转运蛋白2A的SLC34A1基因的常染色体隐性突变导致特发性婴儿高钙血症。
J Am Soc Nephrol. 2016 Feb;27(2):604-14. doi: 10.1681/ASN.2014101025. Epub 2015 Jun 5.
10
Severe hypercalcemic crisis in an infant with idiopathic infantile hypercalcemia caused by mutation in CYP24A1 gene.特发性婴儿高钙血症致 CYP24A1 基因突变引起婴儿严重高钙血症危象
Eur J Pediatr. 2013 Jan;172(1):45-9. doi: 10.1007/s00431-012-1818-1. Epub 2012 Sep 22.

引用本文的文献

1
Targeting Calcitriol Metabolism in Acute Vitamin D Toxicity-A Comprehensive Review and Clinical Insight.靶向急性维生素 D 毒性中的钙三醇代谢:全面综述和临床观察。
Int J Mol Sci. 2024 Sep 17;25(18):10003. doi: 10.3390/ijms251810003.
2
Persistent hypercalcaemia associated with two pathogenic variants in the gene and a parathyroid adenoma-a case report and review.与基因中的两个致病性变异体和甲状旁腺腺瘤相关的持续性高钙血症:病例报告及文献复习。
Front Endocrinol (Lausanne). 2024 Apr 11;15:1355916. doi: 10.3389/fendo.2024.1355916. eCollection 2024.
3
A Case of Delayed Diagnosis of Idiopathic Infantile Hypercalcemia Due to CYP24A1 Mutation: A 10-Year Journey.
一例因CYP24A1突变导致的特发性婴儿高钙血症延迟诊断病例:十年历程
Cureus. 2023 Aug 1;15(8):e42811. doi: 10.7759/cureus.42811. eCollection 2023 Aug.
4
25(OH)D Concentration in Neonates, Infants, Toddlers, Older Children and Teenagers from Poland-Evaluation of Trends during Years 2014-2019.波兰新生儿、婴儿、幼儿、较大儿童和青少年的 25(OH)D 浓度-2014-2019 年期间趋势评估。
Nutrients. 2023 Aug 6;15(15):3477. doi: 10.3390/nu15153477.
5
The cause of severe hypercalcaemia resistant to pamidronate treatment: subcutaneous fat necrosis with no visible skin lesion.对帕米膦酸盐治疗耐药的严重高钙血症的病因:皮下脂肪坏死且无可见皮肤病变。
Sudan J Paediatr. 2022;22(1):98-103. doi: 10.24911/SJP.106-1602681630.
6
Infantile hypercalcemia with novel compound heterozygous mutation in SLC34A1 encoding renal sodium-phosphate cotransporter 2a: a case report.伴有编码肾钠磷协同转运蛋白2a的SLC34A1基因新型复合杂合突变的婴儿高钙血症:一例报告
Ann Pediatr Endocrinol Metab. 2019 Mar;24(1):64-67. doi: 10.6065/apem.2019.24.1.64. Epub 2019 Mar 31.
7
Optimal bone fracture repair requires 24R,25-dihydroxyvitamin D3 and its effector molecule FAM57B2.最佳的骨折修复需要 24R,25-二羟维生素 D3 及其效应分子 FAM57B2。
J Clin Invest. 2018 Aug 1;128(8):3546-3557. doi: 10.1172/JCI98093. Epub 2018 Jul 16.
8
Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.维生素D介导的高钙血症:机制、诊断与治疗
Endocr Rev. 2016 Oct;37(5):521-547. doi: 10.1210/er.2016-1070. Epub 2016 Sep 2.